In contrast, the tumours derived from our isogenic cell lines presented a significant resistance to the three drugs when they re-expressed CYP1B1, which may result from specific alterations of endogenous molecules by CYP1B1, such as oestrogens, the principal CYP1B1 substrate. The gene discussed is CYP1B1; the disease is neoplasm.